A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)

NCT02083289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open Angle-glaucoma

Interventions

DRUG: ONO-9054
DRUG: Latanoprost

Sponsor

Ono Pharmaceutical Co., Ltd.